Glucocorticoid Receptor 

 186 Products   186 Products   1696 Diseases   95004 News 


«12...302303304305306307308309310311312...10671068»
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Role of steroid growth promoter on growth performance and meat quality traits in broiler. (Pubmed Central) -  Jun 22, 2022   
    The current study investigated the effect of dexamethasone (DEX)-a commonly used growth promoter-on the broiler growth rate, meat quality, and muscle biology...We also observed that DEX significantly increased the number of myofibers and decreased the cross-sectional area of myofibers. Based on these findings, we conclude that DEX reduces feed intake, feed efficiency, and growth rate, but might improve meat quality with a potential risk of residual DEX accumulation if fed at a high dose.
  • ||||||||||  dexamethasone / Generic mfg., doxorubicin hydrochloride / Generic mfg.
    Journal:  Biomimetic Micelles to Accurately Regulate the Inflammatory Microenvironment for Glomerulonephritis Treatment. (Pubmed Central) -  Jun 22, 2022   
    In doxorubicin-induced glomerulonephritis models, results revealed that MM/HA-DXM could specifically "homing" to inflammatory renal tissue with 4.33-fold improvement in targeting performance. In addition, in vivo pharmacodynamic results proved that after treatment with MM/HA-DXM, the proteinuria level decreased to 2.33 times, as compared with that of control group, demonstrating a superior therapeutic effect on glomerulonephritis via this collaborative two-pronged anti-inflammatory therapy strategy.
  • ||||||||||  Veramyst (fluticasone furoate nasal spray) / GSK
    Journal:  Anatomically realistic nasal replicas capturing the range of nasal spray drug delivery in adults. (Pubmed Central) -  Jun 22, 2022   
    The PD of fluticasone propionate (FP) and fluticasone furoate (FF) in 40 nasal cavities was statistically analyzed to identify three airway models representing the low, mean, and high PD in adults...They were verified in terms of reproducibility of in vitro data and validated by showing a reasonable agreement with preexisting in vivo MF PD despite differences in administration and defining the regions. The three models are envisioned to potentially facilitate the development of locally-acting nasal sprays and provide a better understanding of how in vitro metrics relate to in vivo regional nasal deposition.
  • ||||||||||  dexamethasone / Generic mfg., ibuprofen / Generic mfg.
    Journal:  A new ent-clerodane diterpene from Detarium microcarpum Guill. & Perr. and its protective potential for osteoporosis. (Pubmed Central) -  Jun 22, 2022   
    Moreover, Compound 9 (vanillic acid) showed a pronounced inhibition (IC 6.5 ± 0.6 μM) on reactive oxygen species (ROS) production, and 10 (4-O-methyl gallic acid) showed a good inhibition with IC as 103.3 ± 2.2 μM, compared with the standard drug ibuprofen (IC 54.2 ± 9.2 μM). Besides, compounds 1-3 and 8-10 were non-cytotoxic against MCF-7, NCI-H460, Hela, and BJ cell lines.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Two new neolignans and an indole alkaloid from the stems of Nauclea officinalis and their biological activities. (Pubmed Central) -  Jun 22, 2022   
    Compounds 1-9 showed weak to moderate inhibitory activity on nitric oxide (NO) production induced by lipopolysaccharide in mouse macrophage RAW 264.7 cells in vitro with IC values comparable to that of dexamethasone. In addition, compounds 1-9 were evaluated for the antibacterial and cytotoxic effects, and the results revealed that these compounds showed no anti-bacterial activity, and compounds 3-6 showed modest cytotoxic activity.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal, Adverse events:  Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids. (Pubmed Central) -  Jun 22, 2022   
    More importantly, Dex-SA was found to significantly reduce Dex-related side effects, as measured by blood glucose, red blood cells and immune cells, etc. At last, molecular docking results were obtained to confirm that Dex-SA could enter the cells by binding specifically with the E-selectin receptor, for combination with glucocorticoid receptors in the cytoplasm to exert pharmacological effects. Our study is expected to contribute a new strategy to the safe and effective targeting treatment of inflammatory diseases.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  A Preliminary Investigation on a Commercial Ovine Pasteurellosis Vaccine Using Clinical and Pathological Endpoints. (Pubmed Central) -  Jun 22, 2022   
    Five weeks postvaccination, all lambs were immunosuppressed using dexamethasone, and intratracheally challenged with 5.2×10 CFU/mL live Mannheimia haemolytica A1 (clinical isolates)...Further confirmatory studies could provide more evidence on the vaccine efficacy. Safety should further be assessed in a field setting involving a large number of animals to enable detection of rare vaccine adverse events.
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Review, Journal:  Rituximab for thyroid-associated ophthalmopathy. (Pubmed Central) -  Jun 22, 2022   
    More participants in the RTX group experienced adverse effects (8/13 versus 3/12; RR 2.46, 95% CI 0.84 to 7.18).  AUTHORS' There is currently insufficient evidence to support the use of RTX in people with TAO. Future studies investigating RTX in people with active TAO may need to be multi-centre in order to recruit enough participants to make an adequate judgement on the efficacy and safety of this novel therapy.
  • ||||||||||  methylprednisolone sodium succinate / Generic mfg.
    Journal:  Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination. (Pubmed Central) -  Jun 22, 2022   
    She was treated with 5 doses of methylprednisolone 1 g and intravenous immunoglobulin (IVIG) 2 g/kg over 5 days...A proper history and physical exam in addition to a thorough work-up are necessary for prompt recognition of this condition. Initial treatment should consist of steroids followed by IVIG versus plasmapheresis for those not responsive to steroids.
  • ||||||||||  Review, Journal:  Nonopioid Postoperative Pain Management in Neurosurgery. (Pubmed Central) -  Jun 22, 2022   
    Intraoperative strategies include local anesthetic infiltration with bupivacaine, ropivacaine, and lidocaine; scalp block; steroids such as methylprednisolone, triamcinolone, and dexamethasone; ketamine; acetaminophen; ketorolac; liposomal bupivacaine; dexmedetomidine; and performing awake surgery...Multimodal analgesia may be most effective, with the enhanced recovery after surgery (ERAS) pathway as an example and cognitive-behavioral therapy (CBT) as an adjunct. Patient-specific demographics and clinical factors must be considered in selecting the appropriate approach for a given patient.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection. (Pubmed Central) -  Jun 22, 2022   
    Patient-specific demographics and clinical factors must be considered in selecting the appropriate approach for a given patient. In patients with methylprednisolone pulses, the capacity of the predictive model for hospital discharge including variables collected at 5 days was (area under the curve) 0.816.
  • ||||||||||  hydrocortisone / Generic mfg.
    Journal:  Cortisol Reactivity to a physical stressor in Patients with Depression and Alzheimer's disease. (Pubmed Central) -  Jun 22, 2022   
    The effect size (ES) of cortisol reduction was small for patients with MDD (d=0.402) and trivial for patients with AD (d=0.166) and HC group (d=0.090). All participants show a decreased cortisol reactivity to a physical stressor, which can be associated with an impairment in coping with an acute stressor.
  • ||||||||||  chloroquine phosphate / Generic mfg.
    Journal:  Chloroquine Attenuates Asthma Development by Restoring Airway Smooth Muscle Cell Phenotype Via the ROS-AKT Pathway. (Pubmed Central) -  Jun 22, 2022   
    Using HO and PI3K inhibitor (LY294002), we found that the inhibition of oxidative stress level and ROS-AKT signal by chloroquine may serve as a potential mechanism that dedicates to the restoration of the phenotypic imbalance in ASM cells. Overall, the present findings suggested that chloroquine improves asthmatic airway function by controlling ASM cell phenotype shift, sketching a novel profile of chloroquine as a new therapeutic candidate for airway remodeling.
  • ||||||||||  dexamethasone / Generic mfg.
    Clinical, Journal:  Adrenalectomy Improves Blood Pressure and Metabolic Control in Patients With Possible Autonomous Cortisol Secretion: Results of a RCT. (Pubmed Central) -  Jun 22, 2022   
    P=N/A
    Sixty-two AI outpatients (40-75 years) with AI >1 cm and cortisol after overnight dexamethasone suppression test (F-1mgDST) between 50 and 138 nmol/L were randomized to adrenalectomy (Arm A) or a conservative approach (Arm B)...The F-1mgDST cutoff with the best compromise in predicting the BP amelioration was set at 75 nmol/L (sensitivity 77%, specificity 75%). AI patients with PACS benefit from surgery in terms of BP and glycometabolic control.
  • ||||||||||  hydrocortisone / Generic mfg.
    Retrospective data, Journal:  Meta-Analysis: Shouldn't Prophylactic Corticosteroids be Administered During Cardiac Surgery with Cardiopulmonary Bypass? (Pubmed Central) -  Jun 22, 2022   
    Relative to placebo and high-dose corticosteroids, low-dose corticosteroids (≤20 mg/kg hydrocortisone) during adult cardiac surgery did not increase the risks of myocardial infarction (odds ratio [OR]: 0.96, 95% confidence interval [CI]: 0.43-2.17; p = 0.93)...Furthermore, low-dose corticosteroids significantly shortened the mechanical ventilation times (mean difference [MD]: -2.74 h, 95% CI: -4.14, -1.33; p = 0.0001), intensive care unit (ICU) stay (MD: -1.48 days, 95% CI: -2.73, -0.22; p = 0.02), and hospital stay (MD: -2.29 days, 95% CI: -4.51, -0.07; p = 0.04). Low-dose corticosteroids prophylaxis during cardiac surgery provided significant benefits for adult patients, without increasing the risks of myocardial infarction and other complications.
  • ||||||||||  Ad26.COV2-S / J&J
    Journal:  A case of ChAdOx1 vaccine-induced thrombocytopenia and thrombosis syndrome leading to bilateral adrenal haemorrhage and adrenal insufficiency. (Pubmed Central) -  Jun 22, 2022   
    Vaccine-induced thrombosis and thrombocytopenia (VITT) after vaccination against SARS-CoV-2 with the adenoviral vector-based vaccines ChAdOx1 and Ad26.COV2.S has been associated with adrenal pathology, such as bilateral adrenal vein thrombosis, adrenal cortex haemorrhage and adrenal insufficiency in 6% of patients...After 4 weeks in hospital, she was discharged on warfarin, hydrocortisone and fludrocortisone replacement...There is paucity of data regarding the potential for recovery of adrenal function after bilateral adrenal haemorrhage in the context of VITT, and thus, more studies are needed to inform clinical practice. The need for disease registries for rare conditions, such as VITT, is crucial as direct cooperation and sharing of information by clinicians might enable quicker identification of disease patterns than would have been possible via established reporting tools of adverse events.
  • ||||||||||  cetirizine oral / Generic mfg., methylprednisolone acetate / Generic mfg., montelukast / Generic mfg.
    Journal:  Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis. (Pubmed Central) -  Jun 22, 2022   
    In conclusion, our case demonstrates that a patient with a confirmed polyethylene glycol anaphylaxis could safely receive both doses of the COVID-19 mRNA vaccines in a single step with pre-treatment. We hope that our case will further support the limited role in skin testing to PEG in the assessment of COVID-19 mRNA vaccine allergy and highlight the need for further research to elucidate the mechanism of action behind these allergic reactions.
  • ||||||||||  Darzalex (daratumumab) / J&J, Sarclisa (isatuximab-irfc) / Sanofi
    Journal:  Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myeloma. (Pubmed Central) -  Jun 22, 2022   
    • The presence of an ipsilateral neuroma is associated with worse long-term disability score. Given that pharmacists play an integral role in driving cost-effective use of drugs without compromising efficacy and safety for the end user, educating pharmacists on the key differences between isatuximab and daratumumab can guide the selection of the appropriate anti-CD38 antibody.
  • ||||||||||  Oncaspar liquid (pegaspargase) / Servier
    New trial:  The Whole-course Management of Pegaspargase in ENKTL (clinicaltrials.gov) -  Jun 22, 2022   
    P=N/A,  N=72, Not yet recruiting, 
  • ||||||||||  Sarclisa (isatuximab-irfc) / Sanofi
    Trial completion date, Trial primary completion date, Combination therapy:  SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients (clinicaltrials.gov) -  Jun 22, 2022   
    P1b,  N=60, Active, not recruiting, 
    Given that pharmacists play an integral role in driving cost-effective use of drugs without compromising efficacy and safety for the end user, educating pharmacists on the key differences between isatuximab and daratumumab can guide the selection of the appropriate anti-CD38 antibody. Trial completion date: Dec 2022 --> Aug 2023 | Trial primary completion date: Dec 2022 --> Aug 2023
  • ||||||||||  fluticasone / Generic mfg.
    Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma: The INCA Sun randomized clinical trial (8A - live streamed) -  Jun 22, 2022 - Abstract #ERS2022ERS_4280;    
    P=N/A
    At week 32, 11(11%) active and 21(21%) control patients required add-on biologic therapy OR 0.42, 95%CI [0.189-0.95], p=0.038), 3 of 19(16%) active and 11 of 25(44%) control patients who started on FP 500mcg/day were increased (OR 0.26; 95%CI [0.07–0.99], p=0.049), 26 of 83(31%) active and 13 of 73(18%) control patients were reduced to FP 500mcg/day, OR 2.11, 95%CI [1.01–4.74], p=0.047). Despite a lower treatment burden were no differences in asthma control, lung function, T2 inflammation, nor exacerbations between the two groups.
  • ||||||||||  dexamethasone / Generic mfg.
    Covid Virtual Ward: Are we effectively managing patients in the community following hospitalisation from Acute COVID infection? (8L) -  Jun 22, 2022 - Abstract #ERS2022ERS_4207;    
    Background During the first wave of COVID-19 pandemic, patients were only allowed discharge from hospital after achieving clinical stability, weaned off oxygen therapy and completed Dexamethasone.The COVID Virtual Ward @ Home (CVW@H) model facilitates safe and early discharge, allowing patients to be managed in their preferred place of care...Conclusion CVW@H can safely manage patients with improving covid infections at home and provides a safety for these patients. It also has a significant cost saving potential.
  • ||||||||||  Alenia (budesonide/formoterol) / Ache Lab
    Pharmacovigilance in Brazil: safety of budesonide-formoterol (TP-13 in thematic poster area) -  Jun 22, 2022 - Abstract #ERS2022ERS_3900;    
    It also has a significant cost saving potential. Considering this analysis, we can conclude that the use of a wide-spread molecule, such as budesonide-formoterol combination in Brazil, was associated with a few occurrence of adverse events and, when reported, were mostly non-serious events.
  • ||||||||||  vilanterol (GW642444H) / GSK, Veramyst (fluticasone furoate nasal spray) / GSK
    Once-daily Inhaled therapy and peak flowmetry: How effective in improving adherence and control of Asthma (TP-10 in thematic poster area) -  Jun 22, 2022 - Abstract #ERS2022ERS_3864;    
    we also assess the incorporation of daily peak flowmetry monitoring and its importance in improving adherence we recruit 80 diagnosed Asthmatic patients of different stages and shift them to the once-daily inhaled regime of vilanterol with fluticasone furoate. Once daily regime and peak flowmetry helps in improving adherence and better control of Asthma
  • ||||||||||  budesonide/salbutamol (PT027) / AstraZeneca, Avillion
    Bronchodilator responsiveness testing with inhaled budesonide/formoterol in asthma. (TP-10 in thematic poster area) -  Jun 22, 2022 - Abstract #ERS2022ERS_3859;    
    We found a similar bronchodilator responsiveness between salbutamol and budesonide/formoterol in these 101 asthmatic individuals...*<0.001 Conclusion. Budesonide/formoterol can be used for BRT instead of salbutamol without impacting in the test results.
  • ||||||||||  Striverdi Respimat (olodaterol) / Boehringer Ingelheim
    Assessment of inhaled medications using an in vitro human alveolar microphysiological system. (TP-9 in thematic poster area) -  Jun 22, 2022 - Abstract #ERS2022ERS_3841;    
    This is consistent with clinical data that shows higher retention, and therefore longer lasting effects, of these drugs in lung tissue. The alveolar MPS was predictive of compound dynamics in the lung and will be used to analyse pharmacology and toxicity of inhaled compounds in future studies.
  • ||||||||||  dexamethasone / Generic mfg., hydrocortisone / Generic mfg.
    The influence of sex on the outcomes of premature infants receiving postnatal corticosteroids (TP-16 in thematic poster area) -  Jun 22, 2022 - Abstract #ERS2022ERS_3290;    
    Males were more likely to require repeated courses, mean 1.67 vs females, mean 1.59, p=0.027. Multivariate regression analysis identified no significant difference in outcomes between the sexes after receiving PNS Conclusions Both sexes had similar outcomes after receiving PNS, but a significantly greater number of males met the clinical threshold to receive PNS and were more likely to require multiple courses which exposes them to a greater risk of long-term adverse outcomes
  • ||||||||||  prednisolone / Generic mfg.
    The interest of magnesium sulfate nebulization in asthma exacerbation (TP-15 in thematic poster area) -  Jun 22, 2022 - Abstract #ERS2022ERS_3269;    
    Patients in the placebo group received 0.03 cc /kg of salbutamol + 2.5 cc of saline three times 20 min in combination with each oral prednisolone...The difference in the MPIS score between the two groups was not significant (p > 0.05) for reduced seizures (MPIS less than 10) as well as for severe seizures (MPIS greater to 10). Conclusion The addition of nebulized magnesium sulphate in asthma exacerbation as an adjuvant treatment to standard treatment has shown no benefit